Janssen, Malou
Rijvers, Liza
Koetzier, Steven C.
Wierenga-Wolf, Annet F.
Melief, Marie-José
van Langelaar, Jamie
Runia, Tessel F.
de Groot, Christianne J. M.
Neuteboom, Rinze
Smolders, Joost
van Luijn, Marvin M.
Funding for this research was provided by:
Stichting MS Research (15-490d MS, 16-952 MS 425, 20-490f MS)
Article History
Received: 17 March 2021
Accepted: 28 May 2021
First Online: 9 June 2021
Competing interests
: JS: consultancy and/or lecture fee of Biogen, Merck, Novartis and Sanofi Genzyme. All the other authors declare that there is no conflict of interest.